About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Psoriasis Clinical Trials in Chicago | 23 Studies

Clinical Trials PsoriasisChicago

Psoriasis Clinical Trials in Chicago

Find 23 clinical trials for psoriasis near Chicago, Illinois. Connect with research centers in your area.

All Psoriasis trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 23 trials

Active not recruitingPsoriasis Longitudinal Assessment and RegistryThe purpose of this study is to further evaluate the safety of infliximab, ustekinumab, and guselkumab in patients with plaque and other forms of psoriasis.NCT00508547·Birmingham, Alabama and 319 others

Psoriasis Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic ArthritisTo evaluate efficacy, safety, tolerability, and immunogenicity of AbGn-168H administered intravenously in patients with active psoriatic arthritis.NCT02267642·La Jolla, California and 6 others

CompletedStudy of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis SubjectsThe 13G01 clinical trial is a Phase I/II dose escalation study designed to be conducted in adults with inflammatory arthritis who have persistent moderate or severe swelling in…NCT00126724·Glendale, Arizona and 21 others

CompletedEtanercept and Methotrexate in Combination or as Monotherapy in Psoriatic ArthritisThe purpose of this study is to learn more about the role of etanercept alone or in combination with methotrexate on disease activity in adults with psoriatic arthritis.NCT02376790·Tuscaloosa, Alabama and 137 others

CompletedStudy of Efficacy and Safety of Brodalumab in Subjects With Psoriatic ArthritisThe primary objective of this study is to evaluate the efficacy of brodalumab, compared to placebo, in subjects with psoriatic arthritis.NCT02024646·Peoria, Arizona and 102 others

CompletedA Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic ArthritisThe purpose of this study is to evaluate the effectiveness (improvement of signs and symptoms) and safety of ustekinumab in participants with active psoriatic arthritis.NCT01009086·Encinitas, California and 101 others

RecruitingA Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsTo demonstrate that bimekizumab administered intravenously is noninferior to subcutaneous administration.NCT07290036·Peoria, Arizona and 62 others

CompletedIxekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or OverweightThe main purpose of this study is to demonstrate that when participants with psoriatic arthritis and obesity or overweight in the presence of at least 1 weight-related comorbid…NCT06588296·Avondale, Arizona and 85 others

RecruitingTesting an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOThis phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum…NCT03816345·Birmingham, Alabama and 51 others

TerminatedPsA Treatment With hOKT3γ1 (Ala-Ala)hOKT3gamma1 (Ala-Ala) is a man-made antibody that is commonly used to prevent organ rejection.NCT00239720·Aurora, Colorado and 1 other

RecruitingA Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesPsoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO).NCT06671483·Chandler, Arizona and 187 others

Active not recruitingA Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with active PsA and obesity…NCT06864026·Avondale, Arizona and 54 others

CompletedLight Treatment Effectiveness (LITE) StudyTo compare the effectiveness, safety (tolerability), and duration of treatment response at 12 weeks of home versus office-based narrowband ultraviolet B phototherapy for the…NCT03726489·Birmingham, Alabama and 37 others

CompletedA Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)This study includes two periods.NCT03104400·Huntsville, Alabama and 344 others

CompletedGuselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha AgentThe purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) and inadequate response (IR) and/or intolerance…NCT04936308·Mountain Brook, Alabama and 168 others

CompletedSafety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative ArthritisThe purpose of this research study is to see if patients with juvenile idiopathic arthritis or seronegative arthritis (and related conditions) mount protective immune responses to…NCT00573651·Chicago, Illinois and 3 others

Active not recruitingA Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic DrugsThe purpose of this study is to evaluate the efficacy and safety of deucravacitinib versus placebo in participants with active psoriatic arthritis who are naïve to biologic…NCT04908202·Gilbert, Arizona and 182 others

CompletedA Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic DrugThis is a Phase 3 multicenter study that included two periods.NCT03104374·Mobile, Alabama and 164 others

RecruitingObservational Study of Pediatric Rheumatic Diseases: The CARRA RegistryContinuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases.NCT02418442·Birmingham, Alabama and 81 others

Active not recruitingA Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial DiseaseThe purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) axial disease by assessing reduction in axial…NCT04929210·Avondale, Arizona and 241 others

Page 1 of 2Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia